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Local protein synthesisDendritic spines are specialized structures on neuronal processes where the majority of excitatory synapses are
localized. Spines are highly dynamic, and their stabilization and morphology are inﬂuenced by synaptic activity.
This extrinsic regulation of spinemorphogenesis underlies experience-dependent brain development and infor-
mation storage within the brain circuitry. In this review, we summarize recent ﬁndings that demonstrate the
phenomenon of activity-dependent structural plasticity and themolecularmechanisms bywhich synaptic activ-
ity sculpt neuronal connections. Impaired structural plasticity is associated with perturbed brain function in
neurodevelopmental disorders such as autism. Information from the mechanistic studies therefore provides
important insights into the design of therapeutic strategies for these brain disorders.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Dendritic spines, which were ﬁrst described by Ramón y Cajal more
than one hundred years ago, are the specialized subcellular compart-
ments that characterize dendritic arbors and are where excitatory syn-
apses are located. In the adult mouse neocortex, the majority (96%) of
dendritic spines encapsulate large electron-dense structures known as
the postsynaptic densities that mark synaptic contacts [1]. On the
other hand, very few excitatory synapses are found on the dendritic
shaft. Consequently, the density of dendritic spines directly indicates
the number of excitatory synaptic inputs onto a particular neuron. Den-
dritic spines are largely heterogeneous in both size and shape, even
within a single dendritic segment of a given neuron. The morphology
of dendritic spines can be generally classiﬁed into three classes: the
stubby spine, which lacks an apparent neck; the thin spine, which con-
tains a small bulbous head and a thin, long neck; and the mushroom
spine, which contains a large mushroom-shaped head [2]. In addition,
there are elongated dendritic protrusions called ﬁlopodia, which are
longer than 5 μm (as opposed to spines which typically are b2 μm in
length) and do not possess distinctive heads. Filopodia are more prom-
inent in the developing brain at early postnatal stages and diminish
with adulthood [3]. One prevailing view is that ﬁlopodia represent the
spine precursors during synapse formation [4]. The long necks of
ﬁlopodia would render them highly motile and hence facilitate the
search for presynaptic partners during synaptogenesis. However, it
has also been reported that during the ﬁrst postnatal week, many852 2358 2765.
ights reserved.synaptic contacts occurred directly on dendritic shafts rather than on
the tips of ﬁlopodia [5], suggesting that the pre-requisite of ﬁlopodia
for synaptogenesis might not apply to all synapses [6].
As recently indicated by Yuste [7,8], in order to understand how the
neural circuit functions it is important to ask: Why do excitatory axons
choose to form synapses on dendritic spines rather than the dendritic
shafts of the postsynaptic neuron? Dendritic spines likely offer distinct
advantages for excitatory neurotransmission and function of the brain
circuits. One distinct advantage is that the presence of spine necks
allows the formation of isolated biochemical and electrical compart-
ments, which enable each synapse on a single spine to function and be
regulated independently. It is widely believed that the functional prop-
erty of dendritic spines is highly correlated with their morphology.
Parameters such as the dimension of spine head and spine neck deter-
mine different aspects of dendritic spine function, including the abun-
dance of neurotransmitter receptors, the diffusion of small molecules
between spine and shaft, as well as the motility and stability of the
spine [6]. The narrow spine neck might also compartmentalize calcium
[7], thus allowing the strength of individual synapses to be modulated
differently during synaptic plasticity such as long-term potentiation
(LTP) and long-term depression (LTD). Altered spine morphology has
been observed in neurological disorders such as fragile-X syndrome
[9], underscoring the importance of the tight regulation of spine mor-
phology in proper brain function.
Dendritic spines are highly dynamic during development as well as in
the mature nervous system. Spine formation, turnover and morphology
continue to be modulated in the adult brain by input from the environ-
ment in the form of synaptic activity, which is central to memory forma-
tion and other adaptive changes of the brain. Notably, activity-dependent
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vestigating the molecular mechanisms that underlie structural plas-
ticity of synapses will therefore be crucial not only in understanding
how the brain functions, but should also provide important insights on
identifying therapeutic targets for various neurological disorders. In
this review, we focus on recent progress in (1) demonstrating activity-
dependent spine remodeling during synaptic plasticity and learning/
memory, (2) elucidating molecular mechanisms that underlie activity-
dependent structural plasticity, and (3) delineating the relationship
between impaired spine morphogenesis and neurological disorders.
2. Activity-dependent spine morphogenesis: the phenomenon
2.1. Spine maintenance and maturation
Whereas most recent studies on activity-dependent structural plas-
ticity focus on the rapid spine remodeling in learning-related synaptic
plasticity of the mature brain, it is important to realize that synaptic
transmission and neuronal activity also play key roles in sculpting
neural circuits across development by regulating the maturation and
maintenance of dendritic spines [10]. In dissociated hippocampal neu-
rons, blocking neuronal activity by tetrodotoxin (TTX) reduces spine
number or leads to the appearance of long immature dendritic protru-
sions that lack clear spine heads [11–13]. Excitatory neurotransmission
involving ionotropic glutamate receptors appears particularly impor-
tant to structural plasticity. Pharmacological blockade of AMPA receptor
by NBQX in dissociated hippocampal neurons or organotypic slice cul-
tures also causes spine loss [14,15]. Interestingly, inhibition of NMDA
receptors by APV results in appearance of ﬁlipodia-like processes with-
out reducing density of the total dendritic protrusions, indicating differ-
ential roles for the two types of receptors in spine maintenance and
maturation [14]. Moreover, unlike the situation in dissociated neurons,
blocking neuronal activity by TTX affects neither spine density nor
spine maturation in hippocampal slice culture. This leads to the in-
teresting hypothesis that miniature glutamate release serves to
maintain dendritic spines, which potentially explains why synapses
that might be inactive most of the time can be retained in the adult
brain without elimination [14]. One should emphasize, however,
that contrasting studies have demonstrated an increase in spine den-
sity upon blockade of synaptic transmission (for example, [16–18]),
which can potentially be explained by homeostatic regulation of
structural plasticity.
More insight into activity-dependent spine maintenance has been
gained from in vivo studies using two-photon microscopy. It has long
been suggested that dendritic spines are over-produced during early
postnatal stages, after which extensive spine pruning occurs to reﬁne
the circuit [19]. Spine turnover of the neocortical pyramidal neurons
has been monitored at different postnatal stages, which indicates that
spine elimination indeed exceeds spine formation in adolescent ani-
mals. Spines becomemore stable in the adult brain, when spine pruning
is signiﬁcantly reduced [20,21]. Furthermore, mushroom spines are
more persistent than thin spines, suggesting a correlation between
spine morphology and stability. Time-lapse two-photon imaging
also demonstrates that whisker trimming in mice modulates spine
elimination of layer V pyramidal neurons in the barrel cortex
[22,23]. Likewise, monocular deprivation accelerates spine pruning
on the apical dendrites of layer II/III pyramidal neurons of the visual
cortex [24]. These studies therefore provide compelling evidence
that sensory experience can modify spine stability of neurons in
the relevant cortical region.
2.2. Spine remodeling after induction of synaptic plasticity and learning
Hebbian LTP and LTD are well-studied forms of synaptic plasticity
that form the cellular basis of hippocampal-dependent learning and
memory. It is believed that the persistent changes of synaptic strengthduring late-phase LTP and LTD involve structural changes of the syn-
apse, which include the formation and elimination of synaptic con-
nections and changes in spine morphology. An increase in synaptic
strength by LTP in hippocampal slices is associated with the rapid for-
mation of new spines that depend on NMDA receptor [25,26]. This is
conﬁrmed in dissociated hippocampal neurons upon the induction of
chemically-induced LTP (cLTP) [27,28]. LTP induction also triggers
rapid enlargement of the spine heads [28–30]. Spine enlargement pre-
cedes the increase in AMPA receptor abundance [30] and larger spines
are associated with larger PSD and greater glutamate-induced current
and calcium inﬂux [31,32], suggesting that spine enlargement is essen-
tial for the increased postsynaptic response in LTP. More recent studies
employ two-photon glutamate uncaging to demonstrate NMDA
receptor-dependent enlargement of individual spines, which reconciles
with the input-speciﬁc property of LTP [33,34]. Interestingly, although
structural remodeling is speciﬁc to the stimulated spine, there is cross-
talk to neighboring spines such that the threshold of inducing
subsequent spine enlargement for them is reduced [35,36]. Recently,
LTP-inducing glutamate uncaging has also been shown to stabilize
newly-formed spines: upon stimulation, about half of the new spines
can survive beyond 20 h after their initial growth, as opposed to ~25%
for unstimulated spines of the same neurons [37]. Taken together,
these studies suggest that during LTP, activation of NMDA receptor in-
creases connectivity of speciﬁc neurons through modulation of den-
dritic spines in three different ways: the enlargement of pre-existing
spines, the stabilization of newly-formed spines, and the formation of
new spines.
Contrary to the growth of dendritic spines in response to LTP, a
reduction of synaptic strength during LTD is correlated with spine
shrinkage and retraction [38–40]. Live imaging of dendritic spines
after stimulation by low-frequency uncaging glutamate further demon-
strates that LTD-inducing stimulus leads to spine shrinkage speciﬁcally
on the stimulated spine but not neighboring spines. Therefore, like
LTP-induced spine enlargement, spine shrinkage induced by LTD is
also synapse-speciﬁc [41]. Although size reduction is observed for
both large and small spines, their mechanism is different, such that
the retraction of small spines depends on NMDA receptor, while that
of large spines requires both NMDA receptor and metabotropic gluta-
mate receptor [41]. This latter observation is consistent with studies
showing the involvement of mGluR in experience-dependent structural
plasticity [13,42].
Can the structural plasticity induced by LTP be observed during
natural learning (as opposed to experimental manipulation of sensory
experience such as whisker trimming)? This important question has
been addressed recently by different laboratories using two-photonmi-
croscopy. By monitoring spines of pyramidal neurons in the motor cor-
tex, it has been demonstrated that training mice with a motor learning
task rapidly induces the formation of new spines. Importantly, many of
these new spines can persist for weeks and months after training, and
the mice performance of the motor task positively correlates with the
extent of new spine formation [43,44]. Repetitive motor learning leads
to the formation of new spines in clusters, which also show increased
head size and stability compared to non-clustered new spines. The for-
mation of clustered spines upon repeated training is particularly inter-
esting, since neighboring spines are proposed to function within the
same neural circuit and transmit similar information to the postsynaptic
neuron, therefore encode related memory [45].
3. Activity-dependent spine morphogenesis: the mechanisms
Dendritic spines are enriched in actin, and activity-dependent spine
growth and remodeling depend on signal transduction that modulates
actin dynamics [46,47]. Here, we summarize recent advances in our un-
derstanding of themolecularmechanisms by which activity-dependent
spinemorphogenesis is regulated, focusing in particular on the role and
regulation of small GTPases (Fig. 1).
Fig. 1.Molecular mechanisms by which NMDA receptor activation triggers spine growth and enlargement through modulation of actin dynamics. Activation of Rac1 leads to enhanced
phosphorylation and inhibition of the actin de-polymerization factor coﬁlin, thereby increasing actin polymerization for spine remodeling. The calcium-permeable GluA2-lacking
AMPA receptor is also required for activation of the Rac–PAK pathway, but the underlying mechanisms are not clear. In addition, RhoA activation is implicated in LTP expression and
activity-dependent spine enlargement, but how increased RhoA activity leads to spine enlargement requires further investigation. Dotted arrows represent signaling pathways in
which detailed mechanisms are not clear.
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One important class of signaling molecules that transduce extracel-
lular signals to regulate actin assembly is the small GTPases [48–50].
They are widely accepted as key players in the regulation of spine mor-
phogenesis in response to synaptic activity [51,52]. The best-studied
family members are Rac1 and RhoA, both belong to the Rho family of
small GTPases. Activation of Rac1 facilitates the formation of dendritic
spines and increases spine head volume. In contrast, RhoA activation
prevents spine formation and induces spine shortening [53,54]. The
activity of GTPases is determined by their GTP-loading state and is
therefore tightly regulated by the interplay between guanine nucleotide
exchange factors (GEFs), which activate GTPases by catalyzing the GDP/
GTP exchange, and GTPase-activating proteins (GAPs), which terminate
GTPases activity by hydrolyzing GTP.
3.1.1. Rac1
Multiple calcium/calmodulin-dependent protein kinases (CaMKs)
can functionally link NMDA receptor to Rac1 activation through phos-
phorylation of different GEFs. NMDA receptor activates the Rac1-
speciﬁc GEFs such as Kalirin-7, TIAM1, and β-PIX via CaMK-mediated
phosphorylation, which subsequently enhance Rac1 activity for spine
growth and remodeling [55–57]. The Rac–GEF β-PIX can be phosphory-
lated by CaMKI at Ser-516 that is crucial for its GEF activity [57]. On the
other hand, CaMKII can phosphorylate both Kalirin-7 and TIAM1, and
the CaMKII inhibitor KN-62 abolishes the NMDA receptor-induced GEF
activity of Kalirin-7 [55,56]. CaMKII can also activate Rac1 in a pathway
that bypasses GEF and involves the signaling protein Abl-interactor 1
(Abi1). Prior to activation by NMDA receptor, CaMKII forms a complex
with Abi1 and both proteins are in the resting state. Upon activation
by NMDA receptor, CaMKII becomes activated and phosphorylatesAbi1 at Ser-88, leading to the release of Abi1 and its binding and activa-
tion of Rac1 [58]. The importance of Rac1 in NMDA receptor-dependent
synaptic plasticity and memory formation is supported by studies
showing that mice lacking Kalirin or expressing dominant-negative
PAK, a major downstream target of Rac1, display impaired LTP and
spatial memory [59–61].
Rac1 promotes spine growth through activation of the protein ki-
nases PAK1 and LIMK1. The latter phosphorylates and inhibits the actin
depolymerizing factor ADF/coﬁlin, leading to actin polymerization [62].
Upon LTP induction, rapid increase in phospho-PAK and coﬁlin has
been detected at the synapses [46]. On the other hand, spine shrinkage
after LTD induction is mediated by activation of coﬁlin [40]. The subcel-
lular localization of coﬁlin is also regulated by NMDA receptors, which
recruit coﬁlin to dendritic spines through the scaffold protein β-
arrestin. Moreover, chemical LTD induces the transition of mature spines
to long, ﬁlopodia-like immature spines, and this spine remodeling is
abolished in neurons expressing phospho-mimetic (inactive) coﬁlin or
neurons lacking β-arrestin [63]. The phosphorylation and translocation
of coﬁlin are therefore crucial for activity-dependent spine remodeling.
Is NMDA receptor activation itself necessary and sufﬁcient to induce
the Rac–PAK pathway for activity-dependent structural plasticity?
While NMDA receptor-mediated Ca2+ conductance and the subsequent
activation of CaMKs are essential, multiple lines of evidence suggest that
this is not sufﬁcient to induce the rapid spine remodeling in LTP. For
example, NMDA receptor and CaMKI activation recruits the Ca2+-
permeable GluA2-lacking AMPA receptors at the synapse. This popula-
tion of AMPA receptors is required for cLTP-induced Rac/PAK/LIMK acti-
vation and spine enlargement, as the effect is blocked by IEM-1460, an
inhibitor of the Ca2+-permeable AMPA receptor [64]. Another factor
essential for spine remodeling during LTP is the neurotrophin brain-
derived neurotrophic factor (BDNF), the secretion and synthesis of
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by the soluble extracellular domain of the BDNF receptor TrkB (TrkB-
Fc) blocks the theta-burst stimulation (TBS)-induced actin polymeriza-
tion in dendritic spines [65]. The presence of TrkB-Fc also abolishes
glutamate-induced spine enlargement in hippocampal slices [34].
How does BDNF–TrkB signaling regulate spine remodeling? One
crucial mechanism involves activation of Rac1 through the GEFs Vav
and TIAM1 [66,67]. The Rac-GEF TIAM1 is one of the downstream tar-
gets of BDNF, which induces phosphorylation of TIAM1 at Tyr-829
essential for BDNF-induced neurite outgrowth [68]. Although TrkB is a
receptor tyrosine kinase whose signaling capability depends on the
auto-phosphorylation of tyrosine residues in the intracellular domain,
it also undergoes serine phosphorylation at Ser-478 by the proline-
directed serine/threonine kinase Cdk5 upon BDNF binding [69]. We
found that S478 phosphorylation of TrkB is required for its interac-
tion and activation of TIAM1. The Rac1 activation by BDNF, as well
as glutamate-induced PAK phosphorylation, is abolished in the TrkB
S478A phospho-deﬁcient neurons [67]. Notably, spine enlargement
after glutamate uncaging was signiﬁcantly reduced in hippocampal
neurons lacking the Ser-478 TrkB phosphorylation, indicating its impor-
tance in activity-dependent structural plasticity. The S478A phospho-
deﬁcient mice also show compromised LTP and failed to form spatial
memory in the Morris water maze, underscoring the importance of
TrkB and this phosphorylation event in activity-dependent spine re-
modeling during memory formation [67].3.1.2. RhoA
RhoA negatively regulates spine formation/stabilization and its inhi-
bition is required for activity-dependent spine maintenance. The Rho–
GAP oligophrenin-1 (OPHN1) is required for spine morphogenesis
[70] and deﬁcits in its function are associatedwith intellectual disability
[71]. Knockdown of OPHN1 reduces spine density and excitatory synap-
tic transmission in hippocampal slice culture, and this effect is occluded
by neuronal activity blockade with TTX. Moreover, the presence of TTX
or NMDA receptor antagonist APV impairs the synaptic localization of
OPHN1 [72], suggesting that neuronal activity drives OPHN1 to the den-
dritic spines for RhoA inhibition during spine maintenance. Synaptic
transmission also inhibits RhoA through the Rho–GEF Lfc (also known
as GEF-H1). Lfc interacts with AMPA receptors, causing inhibition of
Lfc. Treatment of cultured hippocampal neurons with the AMPA recep-
tor antagonist NBQX induces spine loss, and this effect is attenuated
by knocking down Lfc expression, indicating that the inhibition of Lfc
and RhoA mediates spine maintenance downstream of AMPA receptor
activation [15]. Our laboratory has also found that activation of the
Eph receptor EphA4 leads to spine loss, which is mediated by RhoA ac-
tivation through the GEF ephexin1 [73]. Given that EphA4 negatively
regulates excitatory synaptic transmission upon prolonged elevation
of synaptic activity [74], it is possible that the EphA4–ephexin1–RhoA
pathway plays an important role in controlling spine density during ho-
meostatic plasticity.
Lfc is recruited to dendritic spines by neuronal activity, where it is
locally activated by interaction with spinophilin and neurabin and
promotes spine maturation through increased RhoA activity [75].
This suggests that RhoA might not only act as a regulator of spine
maintenance/pruning but also is involved in modulating spine matura-
tion and morphology. Indeed, studies on synaptic plasticity suggest
that RhoA is rapidly activated at stimulated spines during glutamate
uncaging-induced spine enlargement, and RhoA activity is essential
for the stable expression of LTP [76,77]. However, knockdown of
OPHN1 also signiﬁcantly reduces cLTP-induced spine enlargement
and the expression of LTP [72]. Therefore, although RhoA is required
for structural plasticity during LTP, its activity needs to be precisely
regulated and over-activation is detrimental. This synaptic plasticity
defect might underlie the cognitive impairment in intellectual dis-
ability, which involves loss-of-function mutations of OPHN1.3.1.3. Ras and Rap
In addition to the Rho family, other small GTPases also play impor-
tant roles in spinemorphogenesis, although their regulation by synaptic
activity and function in synaptic plasticity is less clear when compared
to Rac1 and RhoA. In particular, the role of Ras and Rap, a Ras-like
small GTPase, in spinemorphogenesis has attracted considerable atten-
tion because genes that encode the corresponding GEF or GAP are au-
tism susceptible genes. Rap can be activated by the GEF Epac2 (also
known as RapGEF4), and rare mutations of the epac2 gene have been
identiﬁed in individuals with autism spectrum disorder (ASD) [78].
Epac2 promotes spine shrinkage, and over-expression of the autism-
associated missense mutants of Epac2 leads to altered spine morpholo-
gy in primary cortical neurons [79], therefore pointing towards a poten-
tial link of dysregulated Rap activity and spine morphology to ASD.
Since Rap1 is crucial for synaptic plasticity and memory formation
[80], it is conceivable that Epac2 is also involved in learning-related
structural plasticity. Ras is locally activated in single spines by Ca2+
inﬂux after glutamate-uncaging stimulation, and the spread of Ras to
neighboring spines regulates their induction threshold of structural
plasticity [36]. De novo mutations of SYNGAP1, which leads to trun-
cation of the protein Ras-GAP SYNGAP1, have been identiﬁed in
individuals with intellectual disability and ASD [81,82]. SYNGAP
heterozygous knockout (KO) mice, which model the SYNGAP
haplodeﬁciency in human, show deﬁcits in context discrimination,
a memory task that depends on the dentate gyrus (DG) of the hippo-
campus. Notably, DG neurons with reduced SYNGAP expression
show accelerated spine maturation and increase their spine head
volume spontaneously [83]. Therefore, similar to the situation in
RhoA, Ras is required for activity-dependent spine enlargement,
yet for proper spine development and functioning Ras activity re-
quires tight regulation by GAP to prevent over-activation.
3.2. Local protein synthesis
Given that the maintenance of increased synaptic strength in late-
phase LTP requires protein synthesis [84], it is conceivable that structur-
al plasticity also depends on protein synthesis. The protein synthesis
inhibitor anisomycin inhibits the synapse-speciﬁc spine enlargement
induced by glutamate uncaging [34], indicating that structural plasticity
involves the translation of mRNA. In particular, local dendritic protein
synthesis represents a plausible mechanism by which the morphology
of individual spines is modulated in a synapse-speciﬁc manner [85].
Several lines of evidence support the notion that dendritic protein
synthesis is involved in activity-dependent spine morphogenesis. First,
two major upstream signals that trigger local protein synthesis, namely
BDNF andmGluR, are implicated in activity-dependent spine remod-
eling and maturation [13,34,41,86]. Second, microRNAs that are
dendritically localized regulate spine morphogenesis [86,87]. Third,
manipulation of the mTOR pathway, which is required for LTP and
local protein synthesis, leads to impaired spine morphology and
aberrant behaviors associated with ASD [88–90]. Fourth, abnormal
spine morphology and density are observed in ASD and fragile-X
syndrome, which are associated with dysregulated mTOR signaling
and activity-dependent protein synthesis [91].
Many dendritically-translated mRNAs encode proteins involved in
regulating the GTPase signaling and actin dynamics (Fig. 2). These in-
clude p250GAP, which terminates Rac1 activity [87,92], LIMK1 [86], the
actin-binding protein Arc,which is implicated in actin cytoskeleton orga-
nization [93], and RhoA [94]. These ﬁndings suggest that, in addition to
post-translational control such as phosphorylation, the GTPases-actin
signaling pathway can also be modulated by synaptic activity, perhaps
locally near the synapse, at the level of mRNA translation. It is also note-
worthy that the link between local protein synthesis and GTPase signal-
ing might be bi-directional, since Rac1 and TIAM1 can also regulate the
phosphorylation of p70S6K and PI3K that are involved in protein synthe-
sis regulation [55,67,95,96].
Fig. 2. Local dendritic mRNA translation is coupled to the modulation of Rac1 and RhoA, which might involve the regulated protein synthesis of p250GAP, LIMK, Arc and RhoA, thereby
representing a plausible regulatory mechanism in activity-dependent spine maintenance and remodeling. Although RhoA is generally regarded as a negative regulator of spinogenesis,
RhoA activation is also implicated in spine enlargement during LTP. How RhoA differentially affects actin dynamics for spine shrinkage and enlargement remains unclear. The red and
blue arrows represent an increase and decrease in protein expression, respectively. Dotted arrows represent signaling pathways in which detailed mechanisms are not clear.
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Altered dendritic spine density andmorphology have been associated
with neurodevelopmental disorders such as fragile-X syndrome and Rett
syndrome, themonogenetic disorders which have signiﬁcant phenotypic
overlap with ASD [9,97–101]. Characterized by impaired language and
social interaction, and the presence of repetitive behavior, ASD is a het-
erogeneous disorder that has a high degree of heritability. Raremutations
as well as copy number variants (CNV) have been identiﬁed in ASD indi-
viduals. Notably,many of themutations and variants have been identiﬁed
in genes that encode proteins crucial for spine morphogenesis through
regulation of GTPase activity or cell adhesion [102,103], such as Epac2,
SYNGAP1, CASPR2 and CDKL5 [79,83,104–107]. On the other hand,
genemutations that affect the function of FMRP, TSC2, or PTEN,which in-
directly control spine morphogenesis through the regulation of synaptic
protein synthesis, are also detected in individuals with autistic behavior
or intellectual disability. It is therefore conceivable that disturbance of
spine morphogenesis plays a major pathophysiological role in these
neurodevelopmental disorders.
Fragile-X syndrome is caused by the absence of FMRP, a RNA-
binding protein for dendritic mRNA trafﬁcking and regulation of
activity-dependent protein synthesis. Fragile-X syndrome is charac-
terized by increased spine density and the presence of long and im-
mature spines [9,97–99]. One plausible mechanism underlying the
spine defects is exaggerated protein synthesis and impaired re-
sponse to synaptic activity [108,109]. According to the mGluR theory
of fragile-X syndrome [110], one major consequence of the absence of
FMRP is the increased mGluR-dependent hippocampal LTD, which trig-
gers spine elongation and shrinkage [41,42] and might explain the ap-
pearance of immature spines in Fmr1 KO mice. Group 1 metabotropic
glutamate receptor therefore represents a potential therapeutic target
for fragile-X syndrome, and reduced mGluR5 expression indeed genet-
ically rescues the spine and behavioral defects in Fmr1 KO mice [108].
In addition to aberrant protein synthesis, FMRP deﬁciencies also
impair LTP-induced signaling to the actin cytoskeleton, such as Rac1 ac-
tivation and PAK phosphorylation [111], suggesting a possible defect in
activity-dependent spine remodeling. Expression of dominant-negative
PAK corrects the increased spine density in Fmr1 KO mice, indicatingthat PAK is over-activated in the absence of FMRP [112]. It is not clear
howFMRP regulates theRac–PAK activation, although another study re-
veals that FMRP modulates actin dynamics by suppressing the mRNA
translation of PP2A catalytic subunit, and the up-regulated PP2A in
Fmr1 KO mice increases the de-phosphorylation of coﬁlin [113]. None-
theless, it was recently demonstrated that a small molecule PAK inhibi-
tor can reverse the spine and behavioral phenotypes of Fmr1 KO mice
[114]. This raises the exciting possibility that signaling proteins that reg-
ulate spine morphogenesis represent potential therapeutic targets for
fragile-X syndrome and other forms of autism and intellectual disability.
5. Conclusions and future directions
In this review, we have summarized some of the recent advances in
our understanding of how spinemorphogenesis is regulated by synaptic
activity, which is fundamentally critical to the adaptive function of the
brain. It is clear that the signaling pathways that control spine morpho-
genesis have to be tightly regulated atmultiple levels, and dysregulation
of these pathways, whether it is hyper-or hypo-activated, can lead to
detrimental effects on the cognitive function of the brain. Whereas the
signaling mechanisms of activity-dependent structural plasticity have
been extensively studied in the past decade, the information we have
might only be the tip of the iceberg, and identiﬁcation ofmanymore sig-
naling mechanisms and constituents involved in spine morphogenesis
will be warranted in the future. The growing number of transcriptomic
and proteomic studies on synapse function will undoubtedly provide
important clues in identifying new players. Given the emerging role of
dendritic protein synthesis on synaptic plasticity and spine mainte-
nance, the large-scale identiﬁcation of mRNA transcripts in the synaptic
neuropil of the hippocampus and the mRNA targets of FMRP will be
particularly informative [115,116]. Another promising aspect involves
delineating how spinemorphogenesis is affected by activation of differ-
ent classes of Gs-coupled receptors, which underlie the action of many
neuromodulators of synaptic transmission such as dopamine, prosta-
glandins and serotonin. It is known that PKA is required for LTP-
induced spine enlargement [117], and our laboratory has recently
demonstrated that melanocortin-4 receptor (MC4R) and its ligand
melanocyte-stimulating hormone (α-MSH) promote spine maturation
and enhance LTP through the activation of PKA [118]. Studies on these
2262 K.-O. Lai, N.Y. Ip / Biochimica et Biophysica Acta 1832 (2013) 2257–2263neuromodulators and the associated signaling pathways might provide
signiﬁcant clues in the identiﬁcation and design of cognitive enhancers
for various neurological and neurodegenerative diseases.
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